Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07029919 · ClinicalTrials.gov registry record · NA
Personalized Approach To Habits - Sleep
A NA study of Sleep Disturbance and Adolescent Behavior, sponsored by KDH Research & Communication.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07029919: Recruiting NA study of Sleep Disturbance and Adolescent Behavior, sponsored by KDH Research & Communication.
NCT07029919 is a NA study of Sleep Disturbance and Adolescent Behavior that is actively recruiting participants, run by KDH Research & Communication. The registered enrollment target is 120 participants, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07029919, a NA study of Sleep Disturbance and Adolescent Behavior, is actively recruiting participants, sponsored by KDH Research & Communication.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Two arm study, intervention and control, to explore the impact of an app to help high risk teens with asthma improve their sleep
Primary Outcome
Investigators will ask participants 8 multiple choice knowledge questions related to sleep health and habits which investigators will average to create a composite knowledge score for each participant ranging from 0 to 100. A score of 0 means a participant got zero questions correct while a score of 100 means a participant got all questions correct. Investigators will average these composite scores across all participants for both groups to create mean scores ranging from 0 to 100, the higher th
Conditions Studied
Interventions
- BEHAVIORAL PATH-S app
Study Locations (1)
Georgia
- KDH Research & Communication - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-07-09 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What NCT07029919 shows while recruiting
NCT07029919 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (32% lower).
The record links to 6 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 1 intervention - of which PATH-S app is the first listed.
NCT07029919 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07029919 about?
NCT07029919 is a clinical study titled "Personalized Approach To Habits - Sleep". Two arm study, intervention and control, to explore the impact of an app to help high risk teens with asthma improve their sleep
What is the current status of trial NCT07029919?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-07-09. Estimated completion is 2026-02-28.
What conditions does trial NCT07029919 study?
This clinical trial studies the following conditions: Sleep Disturbance, Adolescent Behavior, Asthma in Children, Knowledge, Attitudes, Practice, Habits.
What interventions are being tested in trial NCT07029919?
The interventions under investigation include: PATH-S app (BEHAVIORAL).
Who is sponsoring clinical trial NCT07029919?
This trial is sponsored by KDH Research & Communication, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07029919 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07029919's enrollment target sits among peer trials
120 19th of 56 higher than 38 of 56 other Sleep Disturbance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disturbance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adjunctive Bright Light Therapy for Opioid Use Disorder
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
RECRUITING · NA
-
Sleep Promotion Program Primary Care
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
SPARK Healthy Sleep
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI